Q2 2025 Earnings Call Transcript July 17, 2025 Abbott Laboratories reports earnings inline with expectations. Reported EPS is ...

Detailed price information for Abbott Laboratories (ABT-N) from The Globe and Mail including charting and trades.

Intuitive Surgical reports earnings with eyes on a 17.1% revenue increase to $2.35 billion. Last quarter, the company surpassed revenue forecasts by 3.1%, hitting $2.25 billion. Despite a mixed ...

Abbott Laboratories ( NYSE: ABT) was upgraded to Buy from Hold at Jefferies following its Q2 results and revised guidance, as analysts view the market reaction as “overly punitive” and see an ...

Detailed price information for Abbott Laboratories (ABT-N) from The Globe and Mail including charting and trades.

Leerink Partners has subtly lowered its FY2025 earnings prediction for Abbott Laboratories, now expecting a profit of $5.14 ...

Reuters is tracking how companies are responding to the threat posed by <a href=" target="_blank" rel="noopener noreferrer ...

Stocks like Sun Pharma, eClerx Services, Indian Energy Exchange, Anant Raj, REC, Aether Industries, Larsen & Toubro, Torrent Power, Enviro Infra Engineers, GR Infraprojects, and Adani Enterprises will ...

The firm saw growth in its core laboratory segment but declines in molecular, point of care, and rapid diagnostics.

Better-than-expected news drove the market higher this week. Inflation readings, retail sales data, unemployment claims, and consumer confidence all showed an economy that continues to outperform ...